ghk-cu wound healing randomized clinical trial Copper Peptide Microneedling in Miami ghk-cu clinical trial human skin

Nowell J, Blunt E, Edison P (2023a) Incretin and insulin signaling as novel therapeutic targets for Alzheimers and Parkinsons disease

Side Effects & Safety No lethal dose found -- toxicology studies couldn't establish an LD50 (Sikiric et al., 2006) No organ toxicity in chronic dosing No hormonal effects -- doesn't affect testosterone, estrogen, cortisol, or GH Mild nausea -- mostly with oral dosing Brief lightheadedness -- occasionally after injection Injection site redness -- standard for SC peptides Angiogenesis concern -- promotes new blood vessel growth, which raises a theoretical question about existing tumors

But for people with normal B12 levels, injections do not reliably cause targeted fat loss

D.et al (2018)

A surgeon can examine your knee, review your imaging, and give you a recovery plan grounded in evidence

Standard dosing protocols The typical GHK-Cu dose ranges from 1 to 2 milligrams per day for most applications